Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis

Kidney International

Volumn 68, Issue 6, 2005, Pages 2714-2725

  Tanaka, Tetsuhiro ^b   Matsumoto, Makiko ^b   Inagi, Reiko ^b   Miyata, Toshio ^b   Kojima, Ichiro ^b   Ohse, Takamoto ^b   Fujita, Toshiro ^b   Nangaku, Masaomi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

Apoptosis; Cobalt; Hypoxia; Hypoxia inducible factor (HIF)

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; COBALT CHLORIDE; ERYTHROPOIETIN; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1BETA; OLMESARTAN; THY 1 ANTIGEN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; GENE EXPRESSION REGULATION; GENE INDUCTION; GLOMERULUS; HISTOLOGY; HYPOXEMIA; INTERSTITIAL NEPHRITIS; KIDNEY ISCHEMIA; KIDNEY TUBULE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; WESTERN BLOTTING;

ANIMALS; ANOXIA; ANTIBODIES; ANTIMUTAGENIC AGENTS; APOPTOSIS; CAPILLARIES; COBALT; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEME OXYGENASE-1; HYPOXIA-INDUCIBLE FACTOR 1; IN SITU NICK-END LABELING; ISOANTIBODIES; KIDNEY TUBULES; MALE; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; REPERFUSION INJURY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 32844456187     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00742.x     Document Type: Article

References (54)

1. FINE L, BANDYOPADHAY D, NORMAN J: Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int (Suppl 75:S22-S26, 2000
2. FINE L, ORPHANIDES C, NORMAN JT: Progressive renal disease: The chronic hypoxia hypothesis. Kidney Int 65:S74-S78, 1998
3. MAZZALI M, JEFFERSON JA, NI Z, et al: Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 63:2088-2093, 2003
4. ORPHANIDES C, FINE LG, NORMAN JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 52:637-647, 1997
5. ECKARDT KU, ROSENBERGER C, JURGENSEN JS, WIESENER MS: Role of hypoxia in the pathogenesis of renal disease. Blood Purif 21:253-257, 2003
6. NANGAKU M: Hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. Nephron Exp Nephrol 98:e8-e12, 2004
7. KANG DH, JOLY AH, OH SW, et al: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12:1434-1447, 2001
8. MACKENSEN-HAEN S, BADER R, GRUND KE, BOHLE A: Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin Nephrol 15:167-171, 1981
9. OHASHI R, KITAMURA H, YAMANAKA N: Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 11:47-56, 2000
10. OHASHI R, SHIMIZU A, MASUDA Y, et al: Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 13:1795-1805, 2002
11. MANOTHAM K, TANAKA T, MATSUMOTO M, et al: Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 15:1277-1288, 2004
12. MATSUMOTO M, TANAKA T, YAMAMOTO T, et al: Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 15:1574-1581, 2004
13. JAAKKOLA P, MOLE DR, TIAN YM, et al: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472, 2001
14. 2 sensing. Science 292:464-468, 2001
15. 2- regulated gene expression. FASEB J 16:1151-1162, 2002
16. WIESENER MS, ECKARDT KU: Erythropoietin, tumours and the von Hippel-Lindau gene: Towards identification of mechanisms and dysfunction of oxygen sensing. Nephrol Dial Transplant 17:356-359, 2002
17. KAELIN WG, JR.: How oxygen makes its presence felt. Genes Dev 16:1441-1445, 2002
18. MATSUMOTO M, MAKINO Y, TANAKA T, et al: Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 14:1825-1832, 2003
19. IO H, HAMADA C, RO Y, et al: Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int 65:1927-1936, 2004
20. SCHRIJVERS BF, FLYVBJERG A, DE VRIESE AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65:2003-2017, 2004
21. MATSUI K, NAGY-BOJARSKY K, LAAKKONEN P, et al: Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 14:1981-1989, 2003
22. RAIJ L, AZAR S, KEANE W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26:137-143, 1984
23. NANGAKU M, PIPPIN J, COUSER W: Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 10:2323-2331, 1999
24. NANGAKU M, PIPPIN J, COUSER W: C6 mediates chronic progression of tubulointerstitial damage in remnant kidney rats. J Am Soc Nephrol 13:928-936, 2002a
25. SHAO J, MIYATA T, YAMADA K, et al: Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. J Am Soc Nephrol 12:2088-2097, 2001
26. SALNIKOW K, DONALD SP, BRUICK RK, et al: Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 279:40337-40344, 2004
27. JEFFERSON JA, JOHNSON RJ: Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 12:297-307, 1999
28. OSTENDORF T, VAN ROEYEN CR, PETERSON JD, et al: A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J Am Soc Nephrol 14:2237-2247, 2003
29. KANG DH, HUGHES J, MAZZALI M, et al: Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12:1448-1457, 2001
30. KIM YG, SUGA SI, KANG DH, et al: Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 58:2390-2399, 2000
31. MASUDA Y, SHIMIZU A, MORI T, et al: Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 159:599-608, 2001
32. TANAKA T, HANAFUSA N, INGELFINGER JR, et al: Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun 309:222-231, 2003
33. TANAKA T, MIYATA T, INAGI R, et al: Hypoxia-induced apoptosis in cultured glomerular endothelial cells - Involvement of mitochondrial pathways. Kidney Int 64:2020-2032, 2003
34. TANAKA T, NANGAKU M, MIYATA T, et al: Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells. J Am Soc Nephrol 15:2320-2333, 2004
35. KHAN S, CLEVELAND RP, KOCH CJ, SCHELLING JR: Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 79:1089-1099, 1999
36. GASSMANN M, HEINICKE K, SOLIZ J, et al: Non-erythroid functions of erythropoietin. Adv Exp Med Biol 543:323-330, 2003
37. PARSA CJ, MATSUMOTO A, KIM J, et al: A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112:999-1007, 2003
38. VESEY DA, CHEUNG C, PAT B, et al: Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19:348-355, 2004
39. SHARPLES EJ, PATEL N, BROWN P, et al: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15:2115-2124, 2004
40. BROUARD S, OTTERBEIN LE, ANRATHER J, et al: Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192:1015-1026, 2000
41. PETRACHE I, OTTERBEIN LE, ALAM J, et al: Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol 278:L312-L319, 2000
42. CHEN K, GUNTER K, MAINES MD: Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 75:304-313, 2000
43. INGUAGGIATO P, GONZALEZ-MICHACA L, CROATT AJ, et al: Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 60:2181-2191, 2001
44. WAGNER M, CADETG P, RUF R. et al: Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. Kidney Int 63:1564-1573, 2003
45. KANELLIS J, FRASER S, KATERELOS M, POWER DA: Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 278:F905-F915, 2000
46. PETERS H, BORDER WA, NOBLE NA: Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54:1570-1580, 1998
47. NOBLE NA, BORDER WA: Angiotensin II in renal fibrosis: Should TGF-beta rather than blood pressure be the therapeutic target? Semin Nephrol 17:455-466, 1997
48. ICHIKAWA I, MIELE JF, BRENNER BM: Reversal of renal cortical actions of angiotensin II by verapamil and manganese. Kidney Int 16:137-147, 1979
49. 2 indicating a novel, potentially renoprotective action. Nephron Physiol 94:p39-p46, 2003
50. MA J, MATSUSAKA T, YANG H, et al: Local actions of endogenous angiotensin II in injured glomeruli. J Am Soc Nephrol 15:1268-1276, 2004
51. NAKAMURA T, OBATA J, KIMURA H, et al: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 55:877-889, 1999
52. ICHIKAWA I: Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int 50:684-692, 1996
53. YOKOI H, MUKOYAMA M, SUGAWARA A, et al: Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 282:F933-F942, 2002
54. HIGGINS DF, BIJU MP, AKAI Y, et al: Hypoxic induction of CTGF is directly mediated by Hif-1. Am J Physiol Renal Physiol 287:F1223-F1232, 2004